FR1586802A - - Google Patents

Info

Publication number
FR1586802A
FR1586802A FR1586802DA FR1586802A FR 1586802 A FR1586802 A FR 1586802A FR 1586802D A FR1586802D A FR 1586802DA FR 1586802 A FR1586802 A FR 1586802A
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Application granted granted Critical
Publication of FR1586802A publication Critical patent/FR1586802A/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D277/82—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/40—Unsubstituted amino or imino radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR1586802D 1964-02-29 1965-03-01 Expired FR1586802A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1114564 1964-02-29

Publications (1)

Publication Number Publication Date
FR1586802A true FR1586802A (fr) 1970-03-06

Family

ID=11769838

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1586802D Expired FR1586802A (fr) 1964-02-29 1965-03-01

Country Status (12)

Country Link
US (1) US3267112A (fr)
BE (1) BE660274A (fr)
BR (1) BR6567513D0 (fr)
DE (1) DE1301321B (fr)
DK (1) DK107874C (fr)
FR (1) FR1586802A (fr)
GB (1) GB1070139A (fr)
IL (1) IL23048A (fr)
LU (1) LU48086A1 (fr)
NL (2) NL6502577A (fr)
NO (1) NO115704B (fr)
SE (1) SE317386B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4263311A (en) * 1976-09-27 1981-04-21 Smithkline Corporation 5,6-Phenyl-2,3-dihydroimidazo [2,1-b] thiazoles
FR2463774A1 (fr) * 1979-08-21 1981-02-27 Yamanouchi Pharma Co Ltd Derives du 2-phenylimidazo(2,1-b)benzothiazole
DE59707350D1 (de) * 1996-04-04 2002-07-04 Rolic Ag Zug Imidazothiazol-Derivate als komponente flüssigkristalline Mischungen
CA2646437C (fr) * 2006-03-17 2016-05-17 Ambit Biosciences Corporation Composes d'imidazolothiazole pour le traitement de maladies
EP2201018B1 (fr) 2007-09-19 2016-03-16 Ambit Biosciences Corporation Formes solides comprenant de la n-(5-tert-butyl-isoxazol-3-yl)-n'-{4-ý7-(2-morpholin-4-yl-éthoxy)imidazoý2,l-b¨ýl,3¨benzothiazol-2-yl¨phényl}urée, compositions en contenant et leurs utilisations

Also Published As

Publication number Publication date
DE1301321B (de) 1969-08-21
IL23048A (en) 1969-04-30
BR6567513D0 (pt) 1973-12-26
LU48086A1 (fr) 1965-04-26
NL129432C (fr)
DK107874C (da) 1967-07-17
NO115704B (fr) 1968-11-18
BE660274A (fr) 1965-06-16
NL6502577A (fr) 1965-08-30
SE317386B (fr) 1969-11-17
US3267112A (en) 1966-08-16
GB1070139A (en) 1967-05-24

Similar Documents

Publication Publication Date Title
FR1586802A (fr)
AU442366B2 (fr)
BE642741A (fr)
BE629793A (fr)
BE628611A (fr)
BE642589A (fr)
BE627390A (fr)
BE642652A (fr)
BE627057A (fr)
BE626684A (fr)
BE626083A (fr)
BE642654A (fr)
BE623398A (fr)
BE661111A (fr)
BE661043A (fr)
BE622126A (fr)
BE621510A (fr)
BE613833A (fr)
BE610935A (fr)
BE603534A (fr)
BE584699A (fr)
BE564626A (fr)
BE554195A (fr)
BE518974A (fr)
BE660840A (fr)

Legal Events

Date Code Title Description
ST Notification of lapse